Page 42 - Markets News
Lupin, Akums, Heritage Foods look relatively strong on charts: Anand James
Anand James of Geojit Investments identified three stocks Lupin, Akums Drugs and Heritage Foods with a favourable technical set-up on charts at current levels.
 "Lupin, Akums, Heritage Foods look relatively strong on charts: Anand James")
SP Group bonds offered at premium on Tata Sons stake-sale plan: Report
SP Group entity Eqyizen Investment had raised 213.50 billion rupees through three-year zero-coupon bonds at a yield of 18.95% in July.
 "SP Group bonds offered at premium on Tata Sons stake-sale plan: Report")
98% transactions to remain unaffected by MDR on UPI: HDFC Securities
Platinum Jasmine A 2018 Trust sold 2 per cent stake in Lenskart Solutions through a block deal on Monday, worth about ₹2,391 crore
 "98% transactions to remain unaffected by MDR on UPI: HDFC Securities")
AIF commitments rise 24% to ₹17.53 trillion as of June 2026: Sebi data
AIF commitments rose nearly 3.5 per cent from March and 23.6 per cent year-on-year, while total investments crossed Rs 7 trillion for the first time
 "AIF commitments rise 24% to ₹17.53 trillion as of June 2026: Sebi data")
NSE IPO receives $10 billion in bids after being subscribed 5.7 times
NSE's $2.3 billion IPO was subscribed 5.7 times by the end of the final day of bidding on Monday as investors bet on continued equity market growth in Asia's third-largest economy.
 "NSE IPO receives $10 billion in bids after being subscribed 5.7 times")
Stock Market Close: Sensex rises 564 pts, Nifty at 23,414; pharma, FMCG, realty top sectoral winners
Sensex Today | Stock Market Highlights, Monday: In the broader markets, the Nifty MidCap and the Nifty SmallCap fell 0.29 per cent and 0.07 per cent, respectively
 "Stock Market Close: Sensex rises 564 pts, Nifty at 23,414; pharma, FMCG, realty top sectoral winners")
Sensex jumps 690 pts intraday, Nifty tops 23,400: 4 factors behind mkt rise
Sensex today: Analysts at SBI Securities said that the gradual decline in crude oil prices over the last four trading sessions has provided some respite to Asian equities.
 "Sensex jumps 690 pts intraday, Nifty tops 23,400: 4 factors behind mkt rise")
Solar Ind snaps 5-day losing streak, gains 4%; MOFSL initiates BUY rating
Motilal Oswal Financial Services (MOFSL) initiate coverage on Solar Industries with a BUY rating and a target price of ₹23,000.
 "Solar Ind snaps 5-day losing streak, gains 4%; MOFSL initiates BUY rating")
Raymond share price jumps 9% on volume spike; stock gains 70% in a year
Raymond stock has gained 5.46 per cent over the past week, 64.43 per cent in the last month, 148.48 per cent year-to-date, and 70.42 per cent over the past year.
 "Raymond share price jumps 9% on volume spike; stock gains 70% in a year")
Unimech soars 7%, up 144% from Mar low; what's driving this defence stock?
Unimech Aerospace: The stock price of the aerospace & defence company quoted higher for the third straight trading day, surging 12 per cent during the period.
 "Unimech soars 7%, up 144% from Mar low; what's driving this defence stock?")
OFSS shares crack 7%; what's spooking Nifty IT's best-performing stock?
As of Friday's close, OFSS shares are up 55 per cent on a year-to-date (YTD) basis, making it the best-performing stock in the worst-performing Nifty IT index.
 "OFSS shares crack 7%; what's spooking Nifty IT's best-performing stock?")
Nifty's 6-week losing run: 9 stocks fall 10-14%; 6 defy trend, add ₹73K cr
Bogged down by crude oil prices trading above $100, the Nifty 50 index has lost 5 per cent during the six-week selloff, which is also its longest since 2020.
 "Nifty's 6-week losing run: 9 stocks fall 10-14%; 6 defy trend, add ₹73K cr")
Pharma stocks zoom: Laurus Labs, Aurobindo hit new highs in trade
The BSE Healthcare index rallied over 1% in Monday's trade. Thus far in the financial year 2026-27, it outperformed the market by soaring 25%, against a near 4% rise in the BSE Sensex.
 "Pharma stocks zoom: Laurus Labs, Aurobindo hit new highs in trade")
Biocon spurts 3% as Pertuzumab drug moves closer to marketing nod in Europe
Biocon jumped nearly 3% in Monday's trade after the company's Pertuzumab biosimilar drug received EMA CHMP recommendation for breast cancer care.
 "Biocon spurts 3% as Pertuzumab drug moves closer to marketing nod in Europe")
INDO-MIM surges 21% in 3 days; up 137% from IPO price in less than 2 months
INDO-MIM's share price hit a new high of ₹1,148, soaring 9 per cent on the BSE in Monday's intra-day deals on the back of a healthy business outlook.
 "INDO-MIM surges 21% in 3 days; up 137% from IPO price in less than 2 months")
When will FIIs return to the Indian stock market? Bernstein answers
Another issue Bernstein highlighted was the nature of India's large-cap companies, which it believes represents a 'bygone economic era'.
 "When will FIIs return to the Indian stock market? Bernstein answers")
Most Tata stocks slip as Tata Sons-Trusts dispute threatens legal battle
Tata stocks: Analysts believe the boardroom battle playing out in public forums is creating more uncertainty for the group.
 "Most Tata stocks slip as Tata Sons-Trusts dispute threatens legal battle")
Block deal alert: Lenskart Solutions slips 3% amid heavy volume on NSE
As of 09:27 AM on Monday, as many as 39.18 million shares representing 2.25 per cent of total equity of Lenskart changed hands on the NSE, the exchange data shows.
 "Block deal alert: Lenskart Solutions slips 3% amid heavy volume on NSE")
Manika Plastech shares make flat market debut, list at par with IPO price
Manika Plastech shares listed flat at ₹43 on both BSE and NSE. The issue was subscribed 28.14 times.
 "Manika Plastech shares make flat market debut, list at par with IPO price")
Tata Capital shares fall even as Emkay sees growth, asset quality on track
Brokerage firm Emkay said, about a year after listing, Tata Capital continues to impress with its execution, with growth, asset quality, credit costs, and profitability broadly tracking guidance
 "Tata Capital shares fall even as Emkay sees growth, asset quality on track")